Acadia Pharmaceuticals Inc. - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
43 Pages - GMD12086
$1,500.00

Summary

Global Markets Direct’s, ‘Acadia Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Acadia Pharmaceuticals Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acadia Pharmaceuticals Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Acadia Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Acadia Pharmaceuticals Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Acadia Pharmaceuticals Inc.’s pipeline products

Reasons to buy

- Evaluate Acadia Pharmaceuticals Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Acadia Pharmaceuticals Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Acadia Pharmaceuticals Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Acadia Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acadia Pharmaceuticals Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Acadia Pharmaceuticals Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Acadia Pharmaceuticals Inc. Snapshot 5
Acadia Pharmaceuticals Inc. Overview 5
Key Information 5
Key Facts 5
Acadia Pharmaceuticals Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Acadia Pharmaceuticals Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Acadia Pharmaceuticals Inc. - Pipeline Products Glance 13
Acadia Pharmaceuticals Inc. - Late Stage Pipeline Products 13
Phase III Products/Combination Treatment Modalities 13
Acadia Pharmaceuticals Inc. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Acadia Pharmaceuticals Inc. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Acadia Pharmaceuticals Inc. - Drug Profiles 18
pimavanserin tartrate 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
AGN-XX/YY 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AC-262271 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AC-74131 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Nurr-1 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
OSU-6162 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule Agonising ER-Beta For Neurology And Pain 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
AC-186 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Acadia Pharmaceuticals Inc. - Pipeline Analysis 27
Acadia Pharmaceuticals Inc. - Pipeline Products by Target 27
Acadia Pharmaceuticals Inc. - Pipeline Products by Route of Administration 29
Acadia Pharmaceuticals Inc. - Pipeline Products by Molecule Type 30
Acadia Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 31
Acadia Pharmaceuticals Inc. - Recent Pipeline Updates 33
Acadia Pharmaceuticals Inc. - Dormant Projects 36
Acadia Pharmaceuticals Inc. - Discontinued Pipeline Products 37
Discontinued Pipeline Product Profiles 37
AM-831 37
Acadia Pharmaceuticals Inc. - Company Statement 38
Acadia Pharmaceuticals Inc. - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
Acadia Pharmaceuticals Inc., Key Information 5
Acadia Pharmaceuticals Inc., Key Facts 5
Acadia Pharmaceuticals Inc. - Pipeline by Indication, 2014 8
Acadia Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9
Acadia Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10
Acadia Pharmaceuticals Inc. - Out-Licensed Products in Pipeline, 2014 11
Acadia Pharmaceuticals Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Acadia Pharmaceuticals Inc. - Phase III, 2014 13
Acadia Pharmaceuticals Inc. - Phase II, 2014 14
Acadia Pharmaceuticals Inc. - Phase I, 2014 15
Acadia Pharmaceuticals Inc. - Preclinical, 2014 16
Acadia Pharmaceuticals Inc. - Discovery, 2014 17
Acadia Pharmaceuticals Inc. - Pipeline by Target, 2014 28
Acadia Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 29
Acadia Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 30
Acadia Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 32
Acadia Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 33
Acadia Pharmaceuticals Inc. - Dormant Developmental Projects,2014 36
Acadia Pharmaceuticals Inc. - Discontinued Pipeline Products, 2014 37
Acadia Pharmaceuticals Inc., Subsidiaries 41

List of Figures
Acadia Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2014 7
Acadia Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9
Acadia Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10
Acadia Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2014 27
Acadia Pharmaceuticals Inc. - Pipeline by Top 10 Route of Administration, 2014 29
Acadia Pharmaceuticals Inc. - Pipeline by Top 10 Molecule Type, 2014 30
Acadia Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 31

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax